|
- Diagnostics - Global - World Health Organization (WHO)
Diagnostics are the most important tools that empower the health workforce in the identification of diseases or health conditions They allow the initiation of treatments in order to avoid further complications and costly treatments for patients
- In vitro diagnostics - Global - World Health Organization (WHO)
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections In vitro simply means ‘in glass’, meaning these tests are typically conducted in test tubes and similar equipment, as opposed to in vivo tests, which are conducted in the body itself
- WHO releases new list of essential diagnostics; new recommendations for . . .
The World Health Organization (WHO) has released its 2023 Essential Diagnostics List (EDL), which is an evidence-based register of in vitro diagnostics (IVD) that supports countries to make national diagnostic choices
- WHO publishes new Essential Diagnostics List and urges countries to . . .
To address the lack of access to tests and testing services in multiple countries, WHO since 2018 has published a yearly essential diagnostics list (EDL), a basket of recommended in vitro diagnostics that should be available at point-of-care and in laboratories in all countries to increase timely and life-saving diagnoses The latest edition, published today, includes WHO-recommended COVID-19
- Landscape analysis of commercially available and pipeline in vitro . . .
The Landscape analysis of commercially available and pipeline in vitro diagnostics for fungal priority pathogens focuses on commercially available diagnostic products and pipeline diagnostic products for invasive fungal diseases (IFDs) and on the identifiable gaps
- Redefining the HIV response in Africa through local production of . . .
To boost supply chain resilience and regional self-reliance, WHO has been actively advocating for locally manufactured quality-assured medicines and diagnostics In 2023, a Kenya-based pharmaceutical company became the first African manufacturer to receive WHO prequalification to produce tenofovir disoproxil fumarate, lamivudine and dolutegravir (TLD), a WHO-recommended first-line
- 6. TB research innovation
TB diagnostics The diagnostic pipeline continues to expand In August 2025, there were almost 100 products in development (Table 6 1) Tests for TB disease that are in development include new biomarker-based point-of-care (POC) and near-POC products that may lead to the establishment of new diagnostic classes
- Global Diagnostics Coalition
The Global Diagnostics Coalition is a WHO managed network, administered and housed within WHO It has 3 objectives: Conduct advocacy activities that raise awareness and increase support of WHO diagnostic leadership and capacity strengthening efforts as essential health services for management of all health conditions Conduct advocacy activities to raise awareness of the essential role of
|
|
|